HERTIA JOHN 4

4 · BIO-RAD LABORATORIES, INC. · Filed Sep 9, 2019

Insider Transaction Report

Form 4

Period: 2019-09-05

BIO-RAD LABORATORIES, INC.BIO, BIOB

HERTIA JOHN

Executive Vice President

Transactions

Exercise/Conversion
Bio-Rad A Common Stock
2019-09-06$326.15/sh+600$195,690→ 22,499 total
Sale
Bio-Rad A Common Stock
2019-09-06$336.80/sh−1,231$414,601→ 18,697 total
Sale
Bio-Rad A Common Stock
2019-09-06$338.97/sh−543$184,061→ 17,404 total
Tax Payment
Bio-Rad A Common Stock
2019-09-05$339.48/sh−208$70,612→ 15,299 total
Sale
Bio-Rad A Common Stock
2019-09-06$340.00/sh−100$34,000→ 17,304 total
Tax Payment
Bio-Rad A Common Stock
2019-09-07$335.59/sh−298$100,006→ 17,606 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-09-06−2,400→ 600 total
Exercise: $119.54Exp: 2024-09-10→ Bio-Rad A Common Stock (2,400 underlying)
Exercise/Conversion
Bio-Rad A Common Stock
2019-09-05+600→ 15,507 total
Exercise/Conversion
Bio-Rad A Common Stock
2019-09-06$119.54/sh+2,400$286,896→ 17,699 total
Exercise/Conversion
Bio-Rad A Common Stock
2019-09-06$139.56/sh+1,800$251,208→ 19,499 total
Exercise/Conversion
Bio-Rad A Common Stock
2019-09-06$159.32/sh+1,200$191,184→ 20,699 total
Sale
Bio-Rad A Common Stock
2019-09-06$334.77/sh−700$234,339→ 21,799 total
Sale
Bio-Rad A Common Stock
2019-09-06$335.64/sh−1,871$627,982→ 19,928 total
Sale
Bio-Rad A Common Stock
2019-09-06$338.01/sh−750$253,508→ 17,947 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-09-06−1,200→ 1,800 total
Exercise: $215.98Exp: 2027-09-05→ Bio-Rad A Common Stock (1,200 underlying)
Exercise/Conversion
Restricted Stock Units
2019-09-07−600→ 1,200 total
Exercise: $0.00→ Bio-Rad A Common Stock (600 underlying)
Exercise/Conversion
Bio-Rad A Common Stock
2019-09-06$215.98/sh+1,200$259,176→ 21,899 total
Exercise/Conversion
Bio-Rad A Common Stock
2019-09-07+600→ 17,904 total
Exercise/Conversion
Restricted Stock Units
2019-09-05−600→ 1,800 total
Exercise: $0.00→ Bio-Rad A Common Stock (600 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-09-06−1,800→ 1,200 total
Exercise: $139.56Exp: 2025-09-11→ Bio-Rad A Common Stock (1,800 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-09-06−1,200→ 1,800 total
Exercise: $159.32Exp: 2026-09-07→ Bio-Rad A Common Stock (1,200 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2019-09-06−600→ 2,400 total
Exercise: $326.15Exp: 2028-09-04→ Bio-Rad A Common Stock (600 underlying)

Holdings

Bio-Rad A Common Stock
(indirect: By Spouse)
252

Footnotes (14)

[F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
[F10]The option vests in five equal annual installments beginning September 11, 2016.
[F11]The option vests in five equal annual installments beginning September 7, 2017.
[F12]The option vests in five equal annual installments beginning September 5, 2018.
[F13]The option vests in five equal annual installments beginning September 4, 2019.
[F14]The restricted stock units vest in five equal annual installments beginning September 7, 2017.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.29 to $335.22, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.32 to $336.24, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.36 to $337.20, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.63 to $338.44, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.63 to $339.17, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
[F8]The restricted stock units vest in five equal annual installments beginning September 5, 2018.
[F9]The option vests in five equal annual installments beginning September 10, 2015.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT